News

Further STEMI progress requires new focus


 

EXPERT OPINION FROM THE ANNUAL CARDIOVASCULAR CONFERENCE AT SNOWMASS

Dr. Gersh reported that he serves as a consultant to Abbott, Boston Scientific, GE Healthcare, and other companies.

b.jancin@elsevier.com

Pages

Recommended Reading

Pregnancy Loss Boosts Multiple Atherosclerotic Risks
MDedge Cardiology
Guidelines Update Approaches to Stable Ischemic Heart Disease
MDedge Cardiology
Prasugrel's use grows, but often off label
MDedge Cardiology
ED syncope observation protocol safely saves money
MDedge Cardiology
Hospital readmissions under attack
MDedge Cardiology
Stopping aspirin after bleeding ulcer raises CV death rate sixfold
MDedge Cardiology
ED troponin testing called big time saver
MDedge Cardiology
Kawasaki disease: long-term cardiovascular risk quantified
MDedge Cardiology
Further STEMI progress requires new focus
MDedge Cardiology
Anticoagulant dabigatran ups the required dose of heparin
MDedge Cardiology